Cresemba and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Zolpidem (zolpidem tartrate). Common drug interactions include death among females and drug-induced liver injury among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Zolpidem. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

On Jul, 27, 2026

17 people who take Cresemba and Zolpidem together, and have interactions are studied.

Cresemba and Zolpidem drug interactions.

What are the common drug interactions of Cresemba and Zolpidem, by gender? *:

female:

Death
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Discomfort
Dyspnoea (difficult or laboured respiration)
Hot flush (sudden feelings of heat)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Hypotension (abnormally low blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Platelet count decreased
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

male:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Enterocolitis infectious
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease progression
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Hyperglycaemia (high blood sugar)
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Cresemba and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Hyperglycaemia (high blood sugar)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

30-39:

n/a

40-49:

n/a

50-59:

Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Wheezing (a high-pitched whistling sound made while you breath)

60+:

Death
Enterocolitis infectious
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Malaise (a feeling of general discomfort or uneasiness)
Platelet count decreased
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Febrile neutropenia (fever with reduced white blood cells)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypokalaemia (low potassium)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 41.18%
Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 2 people, 11.76%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 2 people, 11.76%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 11.76%
Embolism Venous (embolus may pass into the arterial system): 2 people, 11.76%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Leukaemia (blood or bone marrow cancer): 1 person, 5.88%
Itching: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously